The Evolution of Cancer Treatment: From Simplistic Strategies to Personalized Prescriptions May 27, 2016December 14, 2022 Arthur N. Brodsky, PhD
Atezolizumab (Tecentriq™) Receives FDA Approval for Bladder Cancer May 19, 2016December 14, 2022 Arthur N. Brodsky, PhD
FDA Approves Nivolumab (Opdivo) for Advanced Hodgkin Lymphoma Patients May 17, 2016December 14, 2022 Arthur N. Brodsky, PhD
#AACR16 Update: Vice President Biden and the National Cancer Moonshot Initiative April 21, 2016December 14, 2022 Arthur N. Brodsky, PhD